Stability Indicating RP-UPLC Method for Impurity Profiling of Darunavir and Ritonavir in Fixed Dose Drug Combination Product

ABSTRACT

Background The goal of the proposed study was to develop and validate stability indicating mass compatible reverse phase UPLC method for impurity profiling of Darunavir Ethanolate and Ritonavir degradation impurities in fixed-dose drug combination products. Materials and Methods The optimized chromatographic condition includes use of Zorbax Bonus C18 column (150x2.1 mm, 1.8 μm) with mobile phase A (Buffer (55): Methanol (45)) and mobile phase B (Acetonitrile: (30) and Methanol (70)), flow rate of 0.22 mL/min and detection at 240 nm with gradient program of 50 min. The method was validated as per ICH quality guideline Q2 (R1) including specificity by forced degradation study to confirm suitability for intended use. Results The observed retention time for Darunavir was 11.4 min and for Ritonavir was 30.0 min. The Limit of Quantitation (LOQ) for all degradation impurities found is 0.05%, equivalent to the reporting threshold level. The method was found linear and accurate in the range of LOQ to 150% with an observed range of % accuracy of 90.1 to 106.3 for all known impurities. The method was found precise based on less than 10.0% RSD and robust for deliberate changes. Considering the use of a volatile mobile phase, the method can be applied for LC-MS-based analysis for mass identification. Conclusion The developed UPLC method was applied for impurity profiling during the release and stability study of Darunavir Ethanolate and Ritonavir in fixed-dose drug combination products.

KEYWORDS

• Method Validation
• Forced degradation
• Linearity
• Accuracy
• Robustness
• Impurity profiling

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.58.2s.58Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 58, ISSUE 2SClinical Efficacy and Safety of Ceftriaxone in Surgical Prophylaxis: A Systematic Review and Meta-AnalysisShwetha Somakumar, S Elstin Anbu Raj, Gabriel Sunil Rodrigues, V Rajesh · pp. s332–s339Original ArticleSame type: Article
• Article · VOLUME 58, ISSUE 2SA Biochemical and Molecular Insight to Wound Healing Properties of Traditional Indian Medicines in Normal and Diabetic RatsSushma Prabhath, Kumar M R Bhat, K. Sreedhara R Pai, Manas Kinra, Karthik Gourishetti · pp. s359–s371Original ArticleSame type: Article
• Article · VOLUME 58, ISSUE 2SChlorogenic Acid, a Potential Glucose-6-Phosphatase Inhibitor: An Approach to Develop a Pre-Clinical Glycogen Storage Disease Type I ModelSantosh B Patil, Pramod C Gadad · pp. s372–s381Original ArticleSame type: Article
• Article · VOLUME 58, ISSUE 2SIdentification of Phorbol Ester and its Degradation by Traditional Purification Method in the Root of Baliospermum montanum (Willd.) Muell. ArgJayshree Vishnupant Changade, Ashwini Shete, Asha Thomas, Rabindra K Nanda · pp. s382–s388Original ArticleSame type: Article